Kite Pharma, Inc. - FORM S-1/A - EX-23.1 - June 11, 2014

Attached files

file filename
S-1/A - S-1/A - Kite Pharma, Inc.d705296ds1a.htm
EX-4.1 - EX-4.1 - Kite Pharma, Inc.d705296dex41.htm
EX-3.3 - EX-3.3 - Kite Pharma, Inc.d705296dex33.htm
EX-3.5 - EX-3.5 - Kite Pharma, Inc.d705296dex35.htm
EX-10.2 - EX-10.2 - Kite Pharma, Inc.d705296dex102.htm
EX-10.3 - EX-10.3 - Kite Pharma, Inc.d705296dex103.htm
EX-10.7 - EX-10.7 - Kite Pharma, Inc.d705296dex107.htm
EX-10.5 - EX-10.5 - Kite Pharma, Inc.d705296dex105.htm
EX-10.4 - EX-10.4 - Kite Pharma, Inc.d705296dex104.htm
EX-10.1 - EX-10.1 - Kite Pharma, Inc.d705296dex101.htm
EX-10.6 - EX-10.6 - Kite Pharma, Inc.d705296dex106.htm
EX-10.8 - EX-10.8 - Kite Pharma, Inc.d705296dex108.htm
EX-10.10 - EX-10.10 - Kite Pharma, Inc.d705296dex1010.htm
EX-10.11 - EX-10.11 - Kite Pharma, Inc.d705296dex1011.htm
EX-10.12 - EX-10.12 - Kite Pharma, Inc.d705296dex1012.htm
EX-10.13 - EX-10.13 - Kite Pharma, Inc.d705296dex1013.htm
EX-10.14 - EX-10.14 - Kite Pharma, Inc.d705296dex1014.htm
EX-5.1 - EX-5.1 - Kite Pharma, Inc.d705296dex51.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Amendment No. 1 to the Registration Statement No. 333-196081 of Kite Pharma, Inc. on Form S-1 of our report dated April 4, 2014, on the financial statements of Kite Pharma, Inc. and to the reference to us under the heading “Experts” in the prospectus.

/s/ Crowe Horwath LLP

New York, New York

June 10, 2014

Kite Pharma, Inc. Reports

Also read